Maxcyte (MXCT) Net Margin Growth (1y) (2021 - 2026)
Maxcyte (MXCT) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 656.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -430.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 201.00 |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | -677.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -677.00 |
| Dec 31, 2025 | 37,623.00 |
| Sep 30, 2025 | -4,025.00 |
| Jun 30, 2025 | 4,360.00 |
| Mar 31, 2025 | 7,184.00 |
| Dec 31, 2024 | -15,513.00 |
| Sep 30, 2024 | 12,916.00 |
| Jun 30, 2024 | -7,262.00 |
| Mar 31, 2024 | 4,862.00 |
| Dec 31, 2023 | 34,916.00 |
| Sep 30, 2023 | 1,880.00 |
| Jun 30, 2023 | -1,177.00 |
| Mar 31, 2023 | 3,558.00 |
| Dec 31, 2022 | -30,466.00 |
| Sep 30, 2022 | -26,500.00 |
| Jun 30, 2022 | -3,960.00 |
| Mar 31, 2022 | -10,456.00 |
| Dec 31, 2021 | -1,041.00 |
| Sep 30, 2021 | 3,206.00 |
| Jun 30, 2021 | 6,426.00 |